MedCap AB (publ) (STO:MCAP)
467.80
+9.80 (2.14%)
May 5, 2026, 2:40 PM CET
MedCap AB Market Cap
MedCap AB has a market cap or net worth of 6.88 billion as of May 5, 2026. Its market cap has increased by 27.90% in one year.
Market Cap
6.88B
Enterprise Value
6.96B
Revenue
2.18B
Ranking
n/a
PE Ratio
30.53
Stock Price
467.80
Market Cap Chart
Since July 4, 2006, MedCap AB's market cap has increased from 37.25M to 6.88B, an increase of 18,367.58%. That is a compound annual growth rate of 30.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 4, 2026 | 6.88B | -16.90% |
| Dec 30, 2025 | 8.28B | -6.99% |
| Dec 30, 2024 | 8.90B | 78.07% |
| Dec 29, 2023 | 5.00B | 55.89% |
| Dec 30, 2022 | 3.21B | 21.63% |
| Dec 30, 2021 | 2.64B | -22.55% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Getinge AB | 49.99B |
| Sectra AB | 49.17B |
| Elekta AB | 20.35B |
| Vitrolife AB | 14.18B |
| Nolato AB | 13.36B |
| Xvivo Perfusion AB | 8.64B |
| CellaVision AB | 2.89B |
| BICO Group AB | 1.52B |